David Fogel News

May 11, 1997

Today's an important day in my personal history. Two decades go by in a blink: 20 years ago today, I was in Maui, working on an evolutionary neural network program for breast cancer detection with Dr. Gene Wasson of Maui Memorial Hospital. 20 years ago today, as...

read more

David Fogel Interviewed for Risk Roundup on Topic of Computational Intelligence

Dr. David Fogel was interviewed by Dr. Jayshree Pandya, founder of the Risk Group and host of Risk Roundup, a cyber-security & strategic security webcast/podcast. David spoke about various avenues for pursuing computational intelligence and the implications for future advancement in improving business operations, clinical research, and predictive analytics, among other topics. (April 23, 2017)

read more

EffectCheck(R) Case Study of Oscar Munoz’ Letter to United Team

On April 11, 2017, United Airlines CEO Oscar Munoz offered an apology letter to the United “Team” (posted publicly on Facebook). Using EffectCheck, I analyzed the emotions evoked in the letter and have posted a case study of suggested improvements to the letter. The case study is also found at: https://www.linkedin.com/pulse/effectcheck-case-study-oscar-munoz-letter-united-team-david-fogel (April 19, 2017)

read more

Publication on Verinurad for the Treatment of Hyperuricemia and Gout

My friend and scientific colleague, Dr. Phil Tan, is lead author on this new publication regarding Verinurad, a URAT1 inhibitor. URAT1 is important in the regulation of uric acid levels and its activity is blocked by certain therapies that reduce the high serum uric acid levels in gout. This article follows up on two other research articles ( doi:10.1038/srep34995 and doi: 10.1093/molbev/msw116) showing that URAT1 underwent changes (mutations in certain amino acids) in human evolution to better control uric acid levels, changes are also targeted by these therapies. Verinurad is the latest URAT1-targeted therapy to be analyzed. Its high potency and specificity make it a potentially safer and more effective treatment for gout.

read more